SCIATICA PILLS — Class II drug recall D-1348-2016
Terminated recall by Murray International Trading Co., Inc., reported 2016-07-20, distributed nationwide. Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/di
| Recall number | D-1348-2016 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Murray International Trading Co., Inc., Brooklyn, NY, United States |
| Recall initiated | 2016-04-20 |
| Classified | 2016-07-11 |
| Reported by FDA | 2016-07-20 |
| Terminated | 2018-06-14 |
| Distributed | Nationwide (US) |
| Quantity | 144 bottles |
| Reason classes | labeling, unapproved product |
Product
SCIATICA PILLS, packaged in 120-count bottles within a box, Made in the Peoples Republic of China, remaining labeling contains Chinese characters.
Reason for recall
Marketed Without An Approved NDA/ANDA: Products marked as dietary supplements have labeling that bears drug/disease claims, making them unapproved drugs.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1348-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.